{"id":119645,"date":"2016-06-30T00:00:00","date_gmt":"2016-06-30T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/report\/epcxsi0615xx-digital-epharma-consumer-2015-strategic-insight-report\/"},"modified":"2026-04-15T10:21:30","modified_gmt":"2026-04-15T10:21:30","slug":"epcxsi0615xx-digital-epharma-consumer-2015-strategic-insight-report-what-condition-groups-are-most-receptive-to-pill","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epcxsi0615xx-digital-epharma-consumer-2015-strategic-insight-report-what-condition-groups-are-most-receptive-to-pill\/","title":{"rendered":"ePharma Consumer 2015 Strategic Insight Report &#8211; What condition groups are most receptive to pill-plus value-adds and help with adherence?"},"content":{"rendered":"<p>While 13% of U.S. online adults overall say they would request a branded prescription drug if they knew it came with additional tools to help them manage their condition, the influence of these value-added resources on medication decisions is much higher for patients in some condition groups. This report explores those conditions, and looks at the types of pill-plus resources patients in those condition groups are most interested in.<\/p>\n<p><strong>Questions answered in this report:<\/strong><br \/>\nWhat condition groups are most receptive to pill-plus value-adds and help with adherence?<\/p>\n","protected":false},"template":"","class_list":["post-119645","report","type-report","status-publish","hentry","report-gateway-digital","digital-study-name-epharma-consumer","digital-geography-united-states","digital-date-855"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/119645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/119645\/revisions"}],"predecessor-version":[{"id":288529,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/119645\/revisions\/288529"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=119645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}